Watch For Semglee to Be "Interchangeable" With Lantus

Semglee (insulin glargine-yfgn U-100) will be the first "interchangeable" biosimilar.

It was originally approved as a new brand of insulin glargine, not a Lantus generic...and switching required a new Rx.

Now Semglee is both biosimilar to, and interchangeable with, Lantus. Biosimilars have to show similar safety, purity, and potency as the original, or "reference," biologic.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote